中国医学前沿杂志(电子版)2023,Vol.15Issue(11):16-20,5.DOI:10.12037/YXQY.2023.11-03
泛发性脓疱型银屑病生物制剂治疗进展
Progress of biologics in the treatment of generalized pustular psoriasis
周明伟 1刘子毓 1姜日花1
作者信息
- 1. 吉林大学中日联谊医院 皮肤科,吉林 长春 130033
- 折叠
摘要
Abstract
Pustular psoriasis is a type of psoriasis characterized by aseptic pustules on an erythematous base.Generalized pustular psoriasis(GPP)significantly affects patients'quality of life and even threatens their lives.The treatments with traditional systemic drugs have some obvious disadvantages,such as slow and limited effects and intolerance.In recent years,the biologics have significantly improved the curative effect of GPP.This paper reviews the progress of biologics in the treatment of GPP,and focuses on the efficacy and safety of these biologics in order to provide reference for the clinical treatment of GPP.关键词
银屑病/生物制剂/泛发性脓疱型银屑病Key words
Psoriasis/Biologics/Generalized pustular psoriasis引用本文复制引用
周明伟,刘子毓,姜日花..泛发性脓疱型银屑病生物制剂治疗进展[J].中国医学前沿杂志(电子版),2023,15(11):16-20,5.